Subscribe To
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the company will participate in the 41st Annual J.P. Morgan Healthcare Conference. Scott Koenig, M.D., Ph.D., President & Chief Executive Officer of MacroGenics, […] The post MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference appear...
Read More
Posted: Jan 4 2023, 22:50
Author Name: forextv
Views: 112522